Brussels, 09/07/2014 (Agence Europe) - On 9 July, the European Commission imposed fines totalling €427.7 million on the French pharmaceutical company Servier and five producers of generic medicines, namely Niche/Unichem, Matrix (now part of Mylan), Teva, Krka and Lupin, for signing a series of deals aimed at protecting Servier's best-selling blood pressure medicine, Perindopril, from price competition by generics in the EU.
“Through a technology acquisition and a series of patent...